Form EFFECT Connect Biopharma Holdin
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 12, 2025 |
| Accession Number: | 0001193125-25-200186 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dr. Gary Lawton Yale-Trained Plastic Surgeon: New Non-Opioid Pain Medication for Recovery Protocols
- QumulusAI Set to Ring the Nasdaq Opening Bell
- RepSpark Is Golf's Commerce Layer: PGA of America Formalizes Strategic Alignment with Ecommerce Platform
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
